Heptamidine dimethanesulfonate Catalog No.:M25312-C Smiles: CN1CCN(CC1)C(=O)C1C([C@H]2CC[C@@H]1O2)C(O)=O

Smiles: CN1CCN(CC1)C(=O)C1C([C@H]2CC[C@@H]1O2)C(O)=O

CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2/C(/CCC[C@@]21C)=C/C=C1/C[C@@H](O)C[C@H](O)C/1=C

once daily for 3 weeks after the onset of stroke) decreases the mortality and recurrence of stroke in SHRSP

CAS Number: 357336-20-0

a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial

Heptamidine dimethanesulfonate Catalog No.:M25312-C Smiles: CN1CCN(CC1)C(=O)C1C([C@H]2CC[C@@H]1O2)C(O)=OHeptamidine dimethanesulfonate (SBi4211 dimethanesulfonate) is a potent Pentamidine related inhibitor of the calcium binding protein S100B (Kd=6. 9 M), selectively kills melanoma cells with S100B over those without S100B. Heptamidine is a useful tool for the investigation of Myotonic dystrophy (DM). Product information CAS Number: 161374 55 6 Molecular Weight: 560. 68 Formula: C23H36N4O8S2 Chemical Name: 4 {[7 (4